KSH01 injection

DRUG2 trials

Sponsors

TCRx Therapeutics Co.Ltd

Conditions

Refractory Solid TumorsRelapsed Solid TumorsSolid TumorTCR-T Cells

Early Phase 1

KSH01-TCRT Solid Tumors

RecruitingNCT05539833

TCRx Therapeutics Co.LtdRefractory Solid Tumors, Relapsed Solid Tumors, TCR-T Cells

Start: 2022-08-19End: 2027-07-31Target: 50Updated: 2023-04-03

KSH01-R02-101 Solid Tumors

RecruitingNCT05580796

TCRx Therapeutics Co.LtdSolid Tumor

Start: 2022-10-11End: 2027-10-11Target: 50Updated: 2023-04-03